ANUH PHARMA LTD.
NSE : NABSE : 506260ISIN
CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse
: Private
BSE118.2511.95 (+11.24 % )
PREV CLOSE (Rs.) 106.30
OPEN PRICE (Rs.) 106.30
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 188376
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 29-Jan-2021 | 09-Feb-2021 | Quarterly Results |
| 26-Oct-2020 | 06-Nov-2020 | Quarterly Results |
| 29-Jul-2020 | 07-Aug-2020 | Bonus issue & Quarterly Results |
| 04-Jun-2020 | 19-Jun-2020 | Audited Results |
| 17-Feb-2020 | 21-Feb-2020 | ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 21st February, 2020, will inter-alia to consider and approve the following items: 1) Declaration of Interim Dividend for the Financial Year 2019-20; and 2)Fixing of Record Date. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Sunday, February 16, 2020 till 48 hours after the declaration of Interim Dividend i.e. upto Sunday, February 23, 2020. |
| 04-Feb-2020 | 10-Feb-2020 | Preferential Issue of shares Inter alia, to consider: 1. Further fund raising by issue of Equity shares on preferential basis; 2. Postal Ballot Notice; 3. Declaration of Interim Dividend for the Financial Year 20 19-20; 4. Fixing of Record Date. & Interim Dividend & Quarterly Results |
| 27-Jan-2020 | 10-Feb-2020 | Quarterly Results |
| 01-Nov-2019 | 12-Nov-2019 | Quarterly Results |
| 25-Jul-2019 | 07-Aug-2019 | ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2019 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company is scheduled to be held on Wednesday, 7th August, 2019, inter alia to consider and approve Unaudited Financial Results of the Company for the first quarter ended 30th June, 2019. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Monday, July 01, 2019 till Friday, 9th August, 2019. |
| 13-May-2019 | 22-May-2019 | Audited Results & Final Dividend |
